Mission North Hires Tom Blim to Lead Digital and Content Services
NEW YORK, Dec. 9, 2024 /PRNewswire/ — Mission North, a leading strategic communications agency, announces the appointment of Tom Blim as…
Benuta Selects Constructor’s AI Shopping Assistant and Product Discovery Platform to Personalize Online Shopping Experiences
With Constructor’s AI, Europe’s largest online rug retailer can give shoppers ‘the red carpet treatment’ — providing individualized results and…
bb.q Chicken Celebrates Over 50 Locations Across Canada
TORONTO, Dec. 9, 2024 /CNW/ – bb.q Chicken, the world’s largest Korean fried chicken franchise with over 3,800 locations worldwide,…
Halfpricesoft.com Releases ezW2 2024 with New W2 Checklist for Simplified Tax Filing
HOUSTON, Dec. 9, 2024 /PRNewswire/ — Halfpricesoft.com, a leading provider of innovative tax software solutions, announces the launch of its…
Global Times: China enhances village inspection to crack down on corruption at grassroot level as anti-graft campaign enters uncharted water
BEIJING, Dec. 9, 2024 /PRNewswire/ — “We must carry out village inspections in a solid and in-depth manner to promote…
Researchers Highlight Urgent Need for Land Restoration and Food System Reforms to Protect Climate and Biodiversity
THUWAL, Saudi Arabia, Dec. 9, 2024 /PRNewswire/ — Researchers from King Abdullah University of Science and Technology (KAUST), Saudi Arabia’s leading…
Northern Data Group presents AI-enabled film “The Glass Hermit” by Oscar-winner Shona Heath
The short film will make its global debut in New York, London and LA FRANKFURT, Germany, Dec. 9, 2024 /PRNewswire/…
Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH
BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ — Jacobio Pharma (1167.HK), a clinical-stage oncology company dedicated to developing therapies…
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based regimens demonstrate improved rates of minimal residual disease (MRD) negativity and progression-free survival in patients with newly diagnosed multiple myeloma
New analysis from Phase 3 CEPHEUS study demonstrates 85 percent of patients who achieved MRD negativity (10-6) with DARZALEX FASPRO® were…
Encouraging Efficacy and Safety: CStone Presents Latest Clinical Data on CS5001 for Advanced Lymphoma at the 66th ASH Annual Meeting
CS5001 is so far the first anti-ROR1 ADC known to show clinical anti-tumor activity in both solid tumors and lymphomas. The…
↑